Physician

Harry H Sharata, MD, PH.D.

According to 2025 Medicare claims, Harry Sharata, MD, PH.D. (NPI: 1275595753) practices dermatology in the Madison, WI market, with the plurality of this provider's patient population coming from Dane, WI. This provider's primary affiliated billing organization is ADVANCED DERMATOLOGY, INC. (NPI: 1740303395; TIN: 392034651) and primary practice location at 53566-2045.

Sharata's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,425 traditional Medicare patients, billed 8,694 HCPCS/CPT codes, and received $612,641 in Medicare payments. The top billing code was 88331 (Pathology examination of specimen during surgery, first tissue block). Part D data shows 2,328 prescription claims across 874 beneficiaries totaling $373,187 in drug costs, led by Cyltezo(Cf) Pen (Adalimumab-Adbm). Open Payments data shows 39 records totaling $643. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $69,465 to $373,187. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,317	8,848	$574,195
2016	1,176	8,008	$605,670
2017	1,251	8,815	$600,274
2018	1,156	16,011	$502,044
2019	1,289	18,481	$653,661
2020	1,235	12,176	$485,885
2021	1,302	12,831	$551,512
2022	1,396	11,629	$611,581
2023	1,468	10,167	$600,589
2024	1,425	8,694	$612,641

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	323	817	$69,465
2016	364	981	$108,776
2017	415	1,048	$121,528
2018	486	1,407	$201,478
2019	562	1,708	$219,860
2020	642	1,978	$277,170
2021	722	2,029	$252,378
2022	811	2,267	$280,789
2023	879	2,450	$348,534
2024	874	2,328	$373,187

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
88331	Pathology examination of specimen during surgery, first tissue block	263	419	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	738	1,007	$61
17000	Destruction of precancer skin growth, 1 growth	535	698	$41
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	381	488	$37
17003	Destruction of precancer skin growth, 2-14 growths	438	2,532	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cyltezo(Cf) Pen	Adalimumab-Adbm	22	616	$148,715
Otezla	Apremilast	21	630	$101,930
Clobetasol Propionate	Clobetasol Propionate	181	5,278	$7,162
Acitretin	Acitretin	17	510	$3,911
Ketoconazole	Ketoconazole	243	6,760	$3,695

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	39	$643	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Harry H. Sharata, MD, PH.D.?

Tedicare shows public-source Medicare data for Harry H. Sharata, MD, PH.D. (NPI 1275595753), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Harry H. Sharata, MD, PH.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Harry H. Sharata, MD, PH.D.?

Harry H. Sharata, MD, PH.D. is linked to ADVANCED DERMATOLOGY, INC. (billing NPI 1740303395) in the available physician profile data.

Does Harry H. Sharata, MD, PH.D. have Open Payments data?

Harry H. Sharata, MD, PH.D. has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.